Perrigo (PRGO) Shares Outstanding (Diluted Average) (2012 - 2026)

Perrigo (PRGO) reported Shares Outstanding (Diluted Average) of $138.7 million for Q1 2026, up 0.73% year-over-year from $137.7 million in Q1 2025, and little changed quarter-over-quarter from $138.5 million in Q4 2025.

Perrigo (PRGO) Shares Outstanding (Diluted Average) (2012 - 2026) Analysis & Trends

Perrigo (PRGO) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $138.7 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $138.7 million, up 0.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $138.7 million (up 0.73% YoY), and the FY2025 annual result was $138.5 million, up 0.8% from the prior year.
  • Shares Outstanding (Diluted Average) held at $138.7 million in Q1 2026 per PRGO's latest filing, from $138.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $138.8 million in Q3 2025 and troughed at $134.0 million in Q2 2022.
  • A 5-year average of $136.6 million and a median of $137.1 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) decreased 0.45% in 2022, then climbed 2.0% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $134.5 million in 2022, then climbed by 0.59% to $135.3 million in 2023, then climbed by 1.55% to $137.4 million in 2024, then rose by 0.8% to $138.5 million in 2025, then gained by 0.14% to $138.7 million in 2026.
  • Business Quant data shows PRGO's Shares Outstanding (Diluted Average) at $138.7 million in Q1 2026, $138.5 million in Q4 2025, and $138.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Perrigo 1.55 Bn 1.19 Bn 325.50 Mn 138.70 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 138.70 Mn
Dec 31, 2025 138.50 Mn
Sep 27, 2025 138.80 Mn
Jun 28, 2025 138.20 Mn
Mar 29, 2025 137.70 Mn
Dec 31, 2024 137.40 Mn
Sep 28, 2024 137.30 Mn
Jun 29, 2024 137.10 Mn
Mar 30, 2024 137.60 Mn
Dec 31, 2023 135.30 Mn
Sep 30, 2023 136.60 Mn
Jul 1, 2023 136.60 Mn
Apr 1, 2023 134.90 Mn
Dec 31, 2022 134.50 Mn
Oct 1, 2022 134.40 Mn
Jul 2, 2022 134.30 Mn
Apr 2, 2022 134.00 Mn
Dec 31, 2021 133.60 Mn
Oct 2, 2021 133.80 Mn
Jul 3, 2021 133.40 Mn